4.10 A Deep Dive into CheckMate 649 with Dr. Jeffrey Bien
Today we sit down (in person!) with Dr. Jeff Bien…
Plenary Session - inactive due to federal service · Plenary Session - inactive due to federal service
July 28, 202158m 58sExplicit
Audio is streamed directly from the publisher (feeds.soundcloud.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Today we sit down (in person!) with Dr. Jeff Bien of Stanford University to break down all the details -- from the methods to the statistical analysis to the conclusions -- of the CheckMate 649 trial, which pitted first-line nivolumab plus chemotherapy against chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma.
CheckMate 649: doi.org/10.1016/S0140-6736(21)00797-2
Back us on Patreon! www.patreon.com/plenarysession
Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew
Topics
medicineoncologyhealthpolicy